

Author: Shinagawa R. Masuda S. Sasaki R. Ikura K. Takahata K.
Publisher: Springer Publishing Company
ISSN: 0920-9069
Source: Cytotechnology, Vol.23, Iss.1-3, 1997-01, pp. : 77-85
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Assessment of the Bioactivity of Antibodies against β-Amyloid Peptide in vitro and in vivo
Neurodegenerative Diseases, Vol. 1, Iss. 4-5, 2004-11 ,pp. :






Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2011-12 ,pp. :